GlassScriptPhysician profile
Lauren Bloom
NPI 1306252481
$491.64
in general payments reported to CMS, 2019-2025
9 companies · $193 in 2025
The $193 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $61.46 · 2023: $97.46 · 2024: $139 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $148.64 | 2022-2025 | Mounjaro, Trulicity, Zepbound |
| Amgen INC. | $106.17 | 2023-2025 | Repatha, Otezla, Otezla |
| Novo Nordisk INC | $84.85 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Astellas Pharma US INC | $56.22 | 2024-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $24.22 | 2023 | |
| Abbott Laboratories | $22.18 | 2022 | |
| Exact Sciences Corporation | $18.01 | 2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $16.74 | 2024 | Trelegy Ellipta |
| Dexcom, INC. | $14.61 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Bloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.